However, while the two mutations T351A and T610A described in the current study did not show reduced Miro1 protein levels in fibroblasts, a decrease in the number of MERCs and impaired calcium homeostasis is suggested to be a shared hallmark across all currently known PD-associated Miro1 mutations. Here, RHOT1 is linked to Parkinson disease.